Pfizer Stops Enrollment In COVID-Pill Trial After Latest Lousy Results

Pfizer Paxlovid

“Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid - its COVID-19 antiviral pill - for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree.”

Read Our Latest News

Showing 1 reaction

Please check your e-mail for a link to activate your account.
  • Admin 2
    published this page in RIGHT NOW NEWS 2022-06-17 08:55:23 -0500

This is an independent expenditure prepared and paid for by RIGHT NOW MINNESOTA, 8014 Olson Memorial HWY 55 #543 Golden Valley, MN 55427. It is not coordinated with or approved by any candidate nor is any candidate responsible for it.